DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. [electronic resource]
Producer: 20150721Description: 965 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Apoptosis
- Biomarkers, Tumor -- analysis
- Camptothecin -- analogs & derivatives
- Cell Line, Tumor
- Cell Movement
- Cell Survival
- Chromosomal Proteins, Non-Histone -- analysis
- Colorectal Neoplasms -- chemistry
- Down-Regulation
- Female
- Gene Expression
- Gene Knockdown Techniques
- Humans
- Irinotecan
- Male
- Middle Aged
- Oncogene Proteins -- analysis
- Phenotype
- Poly-ADP-Ribose Binding Proteins
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.